| Income Statement |
| Total Revenue | 2.12M |
|
| Revenues (USD) | 2.12M |
| Cost of Revenue | 2.26M |
| Gross Profit | -134.00K |
| Operating Expenses | 3.79M |
| Research and Development Expense | 728.00K |
| Selling, General and Administrative Expense | 3.07M |
| Operating Income | -3.93M |
| Interest Expense | 827.00K |
| Income Tax Expense | 18.00K |
| Net Income | -4.77M |
| Net Income Common Stock | -4.77M |
| Net Income Common Stock (USD) | -4.77M |
| Consolidated Income | -4.77M |
| Earnings per Basic Share | -0.20 |
| Earnings per Basic Share (USD) | -0.20 |
| Earnings per Diluted Share | -0.20 |
| Earning Before Interest & Taxes (EBIT) | -3.93M |
| Earning Before Interest & Taxes (USD) | -3.93M |
| Weighted Average Shares | 24.66M |
| Weighted Average Shares Diluted | 24.66M |
| Balance Sheet |
| Cash and Equivalents | 5.19M |
| Cash and Equivalents (USD) | 5.19M |
| Trade and Non-Trade Receivables | 1.64M |
| Current Assets | 7.26M |
| Property, Plant & Equipment Net | 93.00K |
| Total Assets | 7.36M |
| Debt Current | 2.34M |
| Total Debt | 7.67M |
| Current Liabilities | 8.29M |
| Debt Non-Current | 5.32M |
| Total Liabilities | 13.61M |
| Accumulated Retained Earnings (Deficit) | -150.98M |
| Accumulated Other Comprehensive Income | -111.00K |
| Shareholders Equity | -13.41M |
| Shareholders Equity (USD) | -13.41M |
| Assets Non-Current | 93.00K |
| Total Debt (USD) | 7.67M |
| Deferred Revenue | 636.00K |
| Liabilities Non-Current | 5.32M |
| Trade and Non-Trade Payables | 2.59M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 11.00K |
| Net Cash Flow from Financing | 5.42M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.43M |
| Capital Expenditure | -16.00K |
| Issuance (Purchase) of Equity Shares | 5.68M |
| Issuance (Repayment) of Debt Securities | 959.00K |
| Net Cash Flow from Investing | -16.00K |
| Net Cash Flow from Operations | -3.93M |
| Effect of Exchange Rate Changes on Cash | -46.00K |
| Share Based Compensation | 364.00K |